NOKOMIS, Fla.--(BUSINESS WIRE)--The executive leadership from Rainbow Coral Corp. (OTCBB: RBCC) announced today that in the coming year it will prioritize new partnerships and acquisitions in the rapidly expanding precision medicine industry. The company is already scheduling important networking events that will feature input from drug and diagnostic innovators, regulators, providers, patient advocates and doctors working to find solutions to the major challenges facing the booming market for precision (or personalized) medicine, which is expected by some analysts to enjoy a compound growth rate of about 9.5 percent through 2017.
Help employers find you! Check out all the jobs and post your resume.